Pub. Date : 2013
PMID : 24391798
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The multikinase inhibitor, sorafenib (Nexavar , BAY43-9006), which inhibits both the Raf/MEK/ERK pathway and several receptor tyrosine kinases (RTKs), has shown significantly therapeutic benefits in advanced hepatocellular carcinoma (HCC). | Sorafenib | EPH receptor B2 | Homo sapiens |
| 2 | The multikinase inhibitor, sorafenib (Nexavar , BAY43-9006), which inhibits both the Raf/MEK/ERK pathway and several receptor tyrosine kinases (RTKs), has shown significantly therapeutic benefits in advanced hepatocellular carcinoma (HCC). | Sorafenib | EPH receptor B2 | Homo sapiens |
| 3 | The multikinase inhibitor, sorafenib (Nexavar , BAY43-9006), which inhibits both the Raf/MEK/ERK pathway and several receptor tyrosine kinases (RTKs), has shown significantly therapeutic benefits in advanced hepatocellular carcinoma (HCC). | Sorafenib | EPH receptor B2 | Homo sapiens |